耳和治疗耐药性抑郁症
Berthold Langguth1, An-Suey Shiao2, Jen-Tsung Lai3
1Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Progress in brain research
|October 8, 2023
概括
耳是对幻影声音的感知,耳障碍影响2-3%的人. 解决抑郁症等并发症对于管理声困扰至关重要,因为因果治疗无法获得.
科学领域:
- 神经科学是一个神经科学.
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 精神病学是一个精神病学.
背景情况:
- 耳是对幻影声音的感知,影响着相当一部分人群.
- 在声 (听觉部分) 和声障碍 (听觉部分加上痛苦) 之间进行区分.
- 高 tinnitus 负担与并发症有关,特别是抑郁症.
研究的目的:
- 探索声和抑郁症之间的关系.
- 讨论 tinnitus 的神经机制.
- 审查抑郁症,耐治疗抑郁症 (TRD),以及它们与耳的联系.
主要方法:
- 关于耳和抑郁症的现有文献的综述.
- 讨论 tinnitus 背后的神经机制.
- 抑郁症和治疗耐药性抑郁症的概述.
主要成果:
- 耳困扰通常与抑郁症等并发症有关.
- tinnitus 痛苦的有效管理可能涉及治疗相关疾病.
- 目前的治疗方案并不能为耳提供因果治愈.
结论:
- 识别和治疗并发症,特别是抑郁症和TRD,对于减少与耳相关的痛苦至关重要.
- 了解 tinnitus 和抑郁症之间的联系对于全面的患者护理至关重要.
- 需要进一步研究耳与抗治疗抑郁症之间的关系.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
260
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
260
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
418
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
418
Depression: Overview
263
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
263
Long-term Depression
30.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.9K
Electroconvulsive Therapy
50
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
50
Psychosis: Goals of Pharmacotherapy
150
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
150


